All In MedTech

Device Trial Radar · NCT06070389

Polysomnography Validation of the Sansa Device

Last checked: Nov 21, 2026Latest source record: Aug 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

533

Actual

Start

Jun 1, 2023

Primary completion

Dec 13, 2023

Study completion Dec 13, 2023

Sponsor

Lead sponsor
Huxley Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 6, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the performance of the Sansa device for the diagnosis of sleep disordered breathing.

Conditions

  • Sleep-Disordered Breathing

Interventions

  • Sansa deviceDevice

    The Sansa device will be used during a single overnight polysomnography study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity and Specificity of the Sansa device to detect sleep disordered breathing compared to polysomnographyTime frame: 1 night

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Pulmonary & Sleep Specialists

    Decatur, Georgia

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.